arrow
Return

Uncovering the individual immunotherapeutic roles of PTPN1 and PTPN2 in T cells during dual inhibition

delete2025-09-22
delete0
delete
OA
AI
L
Luis‐Alberto Pérez‐Quintero
A
Alexandre Poirier
C
Chu-Han Feng
Z
Zuzet Martínez-Córdova
I
Isabelle Aubry
C
Cédric Carli
S
Samaneh Kamyabiazar
A
Alain Pacis
Y
Yevgen Zolotarov
K
Kelly-Anne Pike
J
Jean‐Sébastien Delisle
M
Michel L. Tremblay *
DOI:10.1016/j.isci.2025.113610delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
• Dual, but not single, PTPN1 and PTPN2 loss enhances T cell cytotoxicity • The IL-10/STAT3 signaling emerges as a key driver of enhanced T cell function • Dual inhibition synergizes with PD-1 blockade to improve tumor control in vivo
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

iScience cover
iScience
IF:
4.1
Papers:
5.0K
Citations:
4.1W

Organization

H
Hôpital Maisonneuve-Rosemont
Scholars:
27
Papers: 11
Citations: 1.7K
S
stealth biotech, new-york
Scholars:
1
Papers: 1
Citations: 0
M
McGill University
Scholars:
5.5W
Papers: 4.9W
Citations: 7.0W
researcher View more organizations